Market Insider

In this article HOOD MSFT SPOT MCD Check out the companies making headlines Wednesday before the bell: Coca-Cola (KO) — Coca-Cola jumped 2.9% in the premarket following a profit and revenue beat for the beverage giant, which also raised its full-year forecast. Coca-Cola reported adjusted quarterly earnings of 65 cents per share, 7 cents above a
0 Comments
In this article ENPH FBHS MSFT Photo Illustration by Pavlo Gonchar SOPA Images | LightRocket | Getty Images Check out the companies making headlines in after hours trading: Robinhood — Shares of the stock-trading app declined more than 9% during extended trading after the company’s third-quarter revenue missed expectations amid a slowdown in cryptocurrency trading.
0 Comments
In this article FB DWAC MRNA SNAP Getty Images Check out the companies making headlines in midday trading. Snap – Snap shares plummeted by more than 24% after it reported its quarterly results, which included a revenue miss as well as an earnings beat. The social media company said its advertising business declined due to Apple’s
0 Comments
In this article OMC IBKR NFLX UAL Mario Tama | Getty Images News | Getty Images Check out the companies making headlines after the bell:  United Airlines — Shares of United added about 2% in after-hours trading following the airline’s better-than-expected financial results as travel rebounded in the third quarter. United posted a loss of
0 Comments
Take a look at some of the biggest movers in the premarket: Procter & Gamble (PG) – The consumer products giant beat estimates by 2 cents a share, with quarterly earnings of $1.61 per share. Revenue also topped Wall Street forecasts. P&G said it was facing increasing commodity and transportation costs, however, and its shares
0 Comments
Take a look at some of the biggest movers in the premarket: Zillow (Z) – Zillow slid 6.4% in premarket trading, following a Bloomberg report that the company has temporarily stopped its home-buying service due to overwhelming demand. Revance Therapeutics (RVNC) – Revance shares plunged 33.2% in the premarket after the Food and Drug Administration
0 Comments